OP White Papers - random

1. Systematic Strategy To Reduce The Cost Of Goods Sold 3/26/2026

   Learn key ways to cut biologics manufacturing costs through smarter process design, material choices, and supply resilience — driving more efficient, reliable, and commercially sustainable production.

2. Why An Integrated Approach Ensures Smooth Entry Into The European Market 3/25/2025

   Simplify your EU launch and boost returns. Learn how to manage regulatory hurdles, access a huge patient population, and gain end-to-end commercial support.

3. Regulatory Considerations For Excipients Used In Lipid Nanoparticles 8/15/2024

   Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.

4. Synthetic DNA As An Alternative For Scalable Viral Vector Production 3/30/2026

   Enzymatically synthesized DNA is assessed as a plasmid alternative, showing comparable viral vector yield, quality, and purification, while improving scalability and regulatory flexibility.

5. Accelerating ADC Clinical Development Timelines 8/28/2024

   For ADC developers, obtaining the desired payload can be a challenge, as their synthesis is more complex than most other small molecules. Learn about a more efficient approach to payload synthesis.

6. Leveraging Flow Chemistry 1/22/2026

   Discover how continuous processing cuts waste, improves efficiency, and supports safer, scalable reactions while helping teams meet sustainability goals and speed development.

7. Onshoring Advantage: 7 Forces Reshaping Global Biologics Manufacturing 10/27/2025

   Policy, trade, and security pressures are fundamentally reshaping global biologics manufacturing. Forward-looking companies are onshoring critical programs to mitigate risks to supply chains, IP, and regulatory timelines.

8. Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer 3/24/2025

   Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.

9. Molecular Properties Of PROTACs And The Relationship To Formulation Design 3/4/2025

   Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.

10. Random And Semi-Targeted Integration In Cell Line Development 8/5/2025

    While semi-targeted approaches may offer precision, uncover how they may fall short in overall efficiency and productivity, especially in late-stage manufacturing.